Literature DB >> 19109838

Hepatocyte transplantation in animal models.

Anne Weber1, Marie-Thérèse Groyer-Picard, Dominique Franco, Ibrahim Dagher.   

Abstract

More than 30 years after the first hepatocyte transplant to treat the Gunn rat, the animal model for Crigler-Najjar syndrome, there are still a number of impediments to hepatocyte transplantation. Numerous animal models are still used in work aimed at improving hepatocyte engraftment and/or long-term function. Although other cell sources, particularly hepatic and extrahepatic stem cells, are being explored, adult hepatocytes remain the cells of choice for the treatment of liver diseases by cell therapy. In recent years, diverse approaches have been developed in various animal models to enhance hepatocyte transduction and amplification in vitro and cell engraftment and functionality in vivo. They have led to significant progress in hepatocyte transplantation for the treatment of patients with metabolic diseases and for bridging patients with acute injury until their own livers regenerate. This review presents and considers the results of this work with a special emphasis on procedures that might be clinically applicable. Copyright 2008 AASLD.

Entities:  

Mesh:

Year:  2009        PMID: 19109838     DOI: 10.1002/lt.21670

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  33 in total

Review 1.  Cell therapies for liver diseases.

Authors:  Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

2.  New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases.

Authors:  Jennifer R Ferrer; Attasit Chokechanachaisakul; Jason A Wertheim
Journal:  Curr Transplant Rep       Date:  2015-06-01

Review 3.  Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.

Authors:  Mukaddes Esrefoglu
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

4.  Hepatocyte transplantation.

Authors:  Ragai R Mitry; Robin D Hughes; Anil Dhawan
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

5.  Successful transplantation of human hepatic stem cells with restricted localization to liver using hyaluronan grafts.

Authors:  Rachael A Turner; Eliane Wauthier; Oswaldo Lozoya; Randall McClelland; James E Bowsher; Claire Barbier; Glenn Prestwich; Edward Hsu; David A Gerber; Lola M Reid
Journal:  Hepatology       Date:  2013-01-10       Impact factor: 17.425

Review 6.  Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects.

Authors:  Mustapha Najimi; Florence Defresne; Etienne M Sokal
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

7.  The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver.

Authors:  Peggy Stock; Sandra Brückner; Sabine Ebensing; Madlen Hempel; Matthias M Dollinger; Bruno Christ
Journal:  Nat Protoc       Date:  2010-03-11       Impact factor: 13.491

Review 8.  Cellular therapy for liver disease.

Authors:  Robert C Huebert; Jorge Rakela
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

9.  Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD).

Authors:  Kristen J Skvorak; Elizabeth J Hager; Erland Arning; Teodoro Bottiglieri; Harbhajan S Paul; Stephen C Strom; Gregg E Homanics; Qin Sun; Erwin E W Jansen; Cornelis Jakobs; William J Zinnanti; K Michael Gibson
Journal:  Biochim Biophys Acta       Date:  2009-08-19

10.  Adult-Derived Human Liver Stem/Progenitor Cells Infused 3 Days Postsurgery Improve Liver Regeneration in a Mouse Model of Extended Hepatectomy.

Authors:  Astrid Herrero; Julie Prigent; Catherine Lombard; Valérie Rosseels; Martine Daujat-Chavanieu; Karine Breckpot; Mustapha Najimi; Gisèle Deblandre; Etienne M Sokal
Journal:  Cell Transplant       Date:  2016-09-21       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.